Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Organogenesis (ORGO) had Revenue of $564.17M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$564.17M
Net Income	$20.02M
Cost of Goods Sold	$137.52M
Gross Profit	$426.65M
Operating Expenses	$519.48M
Operating Income	$44.69M
Non-Operating Income/Expense	$2.28M
Pre-Tax Income	$46.97M
Normalized Pre-Tax Income	$46.97M
Income after Taxes	$37.03M
Income from Continuous Operations	$37.03M
Consolidated Net Income/Loss	$37.03M
Normalized Income after Taxes	$37.03M
EBIT	$44.69M
EBITDA	$71.63M
Weighted-Average Shares Outstanding (Basic)	126.74M
Weighted-Average Shares Outstanding (Diluted)	130.25M
Earnings per Share (EPS) (Basic)	$0.16
Earnings per Share (EPS) (Diluted)	$0.15
Balance Sheet Financials
Current Assets	$362.19M
Property, Plant, and Equipment	$103.71M
Long-Term Assets	$236.54M
Total Assets	$598.73M
Current Liabilities	$100.12M
Long-Term Debt	$12.79M
Long-Term Liabilities	$198.48M
Total Liabilities	$298.60M
Common Equity	$300.13M
Tangible Shareholders Equity	$262.21M
Shareholders Equity	$300.13M
Common Shares Outstanding	126.95M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-10.31M
Cash Flow from Investing Activities	$-14.15M
Cash Flow from Financial Activities	$-17.36M
Beginning Cash	$136.15M
End Cash	$94.33M
Increase/Decrease in Cash	$-41.82M
Stock-Based Compensation	$13.30M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.62
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.04
Debt to Equity Ratio	0.07
Gross Margin	75.62%
Operating Margin	7.92%
EBIT Margin	7.92%
EBITDA Margin	12.70%
Pre-Tax Profit Margin	8.33%
Profit Margin	3.55%
Free Cash Flow	$-24.46M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.94
Inventory Turnover	4.64
Receiveable Turnover	2.59
Days Sales in Receivables	140.68
Return on Equity	12.34%
Return on Tangible Equity	14.12%
Return on Assets	6.19%
Return on Investments	11.83%
Book Value Per Share	$2.36
Free Cash Flow per Share	$-0.19
Operating Cash Flow per Share	$-0.08

Data from Zacks Investment Research, Inc.